- Home
- AZZ vs VKTX Comparison
AZZ vs VKTX Comparison
Compare AZZ & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- VKTX
- Stock Information
- Founded
- AZZ 1956
- VKTX 2012
- Country
- AZZ United States
- VKTX United States
- Employees
- AZZ N/A
- VKTX N/A
- Industry
- AZZ Industrial Specialties
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- AZZ Industrials
- VKTX Health Care
- Exchange
- AZZ Nasdaq
- VKTX Nasdaq
- Market Cap
- AZZ 2.7B
- VKTX 3.1B
- IPO Year
- AZZ N/A
- VKTX 2015
- Fundamental
- Price
- AZZ $105.81
- VKTX $30.82
- Analyst Decision
- AZZ Buy
- VKTX Buy
- Analyst Count
- AZZ 7
- VKTX 12
- Target Price
- AZZ $108.00
- VKTX $84.00
- AVG Volume (30 Days)
- AZZ 351.7K
- VKTX 3.9M
- Earning Date
- AZZ 07-09-2025
- VKTX 07-23-2025
- Dividend Yield
- AZZ 0.64%
- VKTX N/A
- EPS Growth
- AZZ 908.98
- VKTX N/A
- EPS
- AZZ 8.62
- VKTX N/A
- Revenue
- AZZ $1,586,498,000.00
- VKTX N/A
- Revenue This Year
- AZZ $8.32
- VKTX N/A
- Revenue Next Year
- AZZ $2.57
- VKTX N/A
- P/E Ratio
- AZZ $12.24
- VKTX N/A
- Revenue Growth
- AZZ 1.70
- VKTX N/A
- 52 Week Low
- AZZ $69.59
- VKTX $18.92
- 52 Week High
- AZZ $113.58
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- AZZ 75.64
- VKTX 65.63
- Support Level
- AZZ $98.26
- VKTX $29.76
- Resistance Level
- AZZ $108.05
- VKTX $32.10
- Average True Range (ATR)
- AZZ 2.88
- VKTX 1.62
- MACD
- AZZ 1.16
- VKTX 0.49
- Stochastic Oscillator
- AZZ 68.59
- VKTX 91.22
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.